Works matching IS 17407745 AND DT 2020 AND VI 17 AND IP 5
Results: 18
COVID-19 impact on multi-site recruitment and enrollment.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A concern about survival time as an endpoint in coronavirus disease 2019 clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 491, doi. 10.1177/1740774520943846
- By:
- Publication type:
- Article
Endpoints for randomized controlled clinical trials for COVID-19 treatments.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 472, doi. 10.1177/1740774520939938
- By:
- Publication type:
- Article
Commentary on Bamat et al.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 560, doi. 10.1177/1740774520941442
- By:
- Publication type:
- Article
Commentary on Parker and Weir.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 567, doi. 10.1177/1740774520941420
- By:
- Publication type:
- Article
Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justification.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 562, doi. 10.1177/1740774520941419
- By:
- Publication type:
- Article
Editorial: Clinical trial design in the era of COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Highly efficient clinical trial designs for reliable screening of under-performing treatments: Application to the COVID-19 Pandemic.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 483, doi. 10.1177/1740774520940227
- By:
- Publication type:
- Article
Protocol adherence rates in superiority and noninferiority randomized clinical trials published in high impact medical journals.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 552, doi. 10.1177/1740774520941428
- By:
- Publication type:
- Article
Clinical trials in the time of a pandemic.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 467, doi. 10.1177/1740774520939871
- By:
- Publication type:
- Article
Cost-benefit of outcome adjudication in nine randomised stroke trials.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 576, doi. 10.1177/1740774520939231
- By:
- Publication type:
- Article
Adjusting for adherence in randomized trials when adherence is measured as a continuous variable: An application to the Lipid Research Clinics Coronary Primary Prevention Trial.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 570, doi. 10.1177/1740774520920893
- By:
- Publication type:
- Article
A comparison of phase I dose-finding designs in clinical trials with monotonicity assumption violation.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 522, doi. 10.1177/1740774520932130
- By:
- Publication type:
- Article
Mindfulness, Education, and Exercise for age-related cognitive decline: Study protocol, pilot study results, and description of the baseline sample.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 581, doi. 10.1177/1740774520931864
- By:
- Publication type:
- Article
Comparison of survival distributions in clinical trials: A practical guidance.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 507, doi. 10.1177/1740774520928614
- By:
- Publication type:
- Article
Double-blinding of an acupuncture randomized controlled trial optimized with clinical translational science award resources.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 545, doi. 10.1177/1740774520934910
- By:
- Publication type:
- Article
Strengthening the interpretability of clinical trial results by assessing the effect of informative censoring on the primary estimand in PRECISION.
- Published in:
- Clinical Trials, 2020, v. 17, n. 5, p. 535, doi. 10.1177/1740774520934747
- By:
- Publication type:
- Article